Landscapes / Targets
FGFR2
11 drugs act on FGFR2, in 17 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs11
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Approved | Sep 2027Phase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Other Solid Tumors, Adult | ||||
| Open drug page | |||||
Infigratinibnot checked |
Tyrosine kinase inhibitor |
Phase 2/3 | Jan 2027Phase 2/3 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | Jan 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Achondroplasia, Hypochondroplasia | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma and 6 more | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2027Phase 2 trial completes | |||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Cholangiocarcinoma,Adult | ||||
| Open drug page | |||||
— |
Phase 1/2 | 16 Jun 2028Phase 1/2 trial completes | |||
| Next date | 16 Jun 2028 · Phase 1/2 trial completes | ||||
| Open drug page | |||||
— |
Phase 2 | 15 Dec 2028Phase 1/2 trial completes | |||
| Next date | 15 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Huadong Medicine · Public 000963.SZ |
Phase 1 | 31 Jan 2027Phase 1 trial completes | ||
| Next date | 31 Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, Squamous Non-small Cell Lung Cancer(NSCLC) | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2027Phase 1 trial completes | |||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2027Phase 1 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
AstraZeneca +1 |
Phase 1 | — | ||
| Also tested for | Muscle Invasive Bladder Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 10 of 11 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026